{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T14:26:21Z","timestamp":1786890381000,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,16]]},"DOI":"10.7759\/cureus.114599","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T14:18:06Z","timestamp":1786889886000},"source":"Crossref","is-referenced-by-count":0,"title":["Metabolic-Protective Strategies for Antipsychotic-Associated Weight Gain in Children and Adolescents: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Ali J","family":"Alhagawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim J","family":"Alhiqwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamad A","family":"Majrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayoub H","family":"Salami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S","family":"Aldawsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A","family":"Shok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atyaf A","family":"Kariri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahlam M","family":"Muharraq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghad K","family":"Juraybi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman M","family":"Alshaiban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.15537\/1658-3175.4426","article-title":"A randomized, double-blind, placebo-controlled trial of metformin treatment for weight gain associated with initiation of risperidone in children and adolescents","volume":"29","author":"Arman S","year":"2008","unstructured":"Arman S, Sadramely MR, Nadi M, Koleini N. A randomized, double-blind, placebo-controlled trial of metformin treatment for weight gain associated with initiation of risperidone in children and adolescents. Saudi Med J. 2008, 29:1130-4.","journal-title":"Saudi Med J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.12.2072","article-title":"A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents","volume":"163","author":"Klein DJ","year":"2006","unstructured":"Klein DJ, Cottingham EM, Sorter M, Barton BA, Morrison JA. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents. Am J Psychiatry. 2006, 163:2072-9. 10.1176\/ajp.2006.163.12.2072","journal-title":"Am J Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2016.1232","article-title":"Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autism spectrum disorder: A randomized clinical trial","volume":"73","author":"Anagnostou E","year":"2016","unstructured":"Anagnostou E, Aman MG, Handen BL, et al.. Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autism spectrum disorder: A randomized clinical trial. JAMA Psychiatry. 2016, 73:928-37. 10.1001\/jamapsychiatry.2016.1232","journal-title":"JAMA Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20714","article-title":"Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial","volume":"19","author":"Correll CU","year":"2020","unstructured":"Correll CU, Sikich L, Reeves G, et al.. Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial. World Psychiatry. 2020, 19:69-80. 10.1002\/wps.20714","journal-title":"World Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2022.0098","article-title":"A double-blind placebo-controlled pilot study of topiramate in manic adolescents treated with olanzapine","volume":"33","author":"DelBello MP","year":"2023","unstructured":"DelBello MP, Bruns KM, Bloom T, Patino Duran LR, Strawn J, Adler CM, Welge J. A double-blind placebo-controlled pilot study of topiramate in manic adolescents treated with olanzapine. J Child Adolesc Psychopharmacol. 2023, 33:126-33. 10.1089\/cap.2022.0098","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref6","article-title":"Melatonin decreases olanzapine induced metabolic side-effects in adolescents with bipolar disorder: a randomized double-blind placebo-controlled trial","volume":"52","author":"Mostafavi A","year":"2014","unstructured":"Mostafavi A, Solhi M, Mohammadi MR, Hamedi M, Keshavarzi M, Akhondzadeh S. Melatonin decreases olanzapine induced metabolic side-effects in adolescents with bipolar disorder: a randomized double-blind placebo-controlled trial. Acta Med Iran. 2014, 52:734-9.","journal-title":"Acta Med Iran"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0046","article-title":"Melatonin for reducing weight gain following administration of atypical antipsychotic olanzapine for adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled trial","volume":"27","author":"Mostafavi SA","year":"2017","unstructured":"Mostafavi SA, Solhi M, Mohammadi MR, Akhondzadeh S. Melatonin for reducing weight gain following administration of atypical antipsychotic olanzapine for adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol. 2017, 27:440-4. 10.1089\/cap.2016.0046","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(25)00273-1","article-title":"Metformin for overweight and obese children and adolescents with bipolar spectrum and related mood disorders treated with second-generation antipsychotics: a randomised, pragmatic trial","volume":"12","author":"DelBello MP","year":"2025","unstructured":"DelBello MP, Welge JA, Klein CC, et al.. Metformin for overweight and obese children and adolescents with bipolar spectrum and related mood disorders treated with second-generation antipsychotics: a randomised, pragmatic trial. Lancet Psychiatry. 2025, 12:893-905. 10.1016\/S2215-0366(25)00273-1","journal-title":"Lancet Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaacop.2023.03.004","article-title":"Metformin for overweight and obese children with bipolar spectrum disorders treated with second-generation antipsychotics (MOBILITY): protocol and methodological considerations for a large pragmatic randomized clinical trial","volume":"1","author":"Welge JA","year":"2023","unstructured":"Welge JA, Correll CU, Sorter MT, et al.. Metformin for overweight and obese children with bipolar spectrum disorders treated with second-generation antipsychotics (MOBILITY): protocol and methodological considerations for a large pragmatic randomized clinical trial. JAACAP Open. 2023, 1:60-73. 10.1016\/j.jaacop.2023.03.004","journal-title":"JAACAP Open"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbae173","article-title":"The optimal dosage and duration of metformin for prevention and treatment of antipsychotic-induced weight gain: an updated systematic review and meta-analysis","volume":"51","author":"Peng TR","year":"2025","unstructured":"Peng TR, Chen JA, Lee JA, Hsing CP, Lee MC, Chen SM. The optimal dosage and duration of metformin for prevention and treatment of antipsychotic-induced weight gain: an updated systematic review and meta-analysis. Schizophr Bull. 2025, 51:625-36. 10.1093\/schbul\/sbae173","journal-title":"Schizophr Bull"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena G","year":"2017","unstructured":"Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017, 60:1577-85. 10.1007\/s00125-017-4342-z","journal-title":"Diabetologia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12334","article-title":"Predicting adult obesity from childhood obesity: a systematic review and meta-analysis","volume":"17","author":"Simmonds M","year":"2016","unstructured":"Simmonds M, Llewellyn A, Owen CG, Woolacott N. Predicting adult obesity from childhood obesity: a systematic review and meta-analysis. Obes Rev. 2016, 17:95-107. 10.1111\/obr.12334","journal-title":"Obes Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000502293","article-title":"Lifestyle interventions for weight management in people with serious mental illness: a systematic review with meta-analysis, trial sequential analysis, and meta-regression analysis exploring the mediators and moderators of treatment effects","volume":"88","author":"Speyer H","year":"2019","unstructured":"Speyer H, Jakobsen AS, Westergaard C, et al.. Lifestyle interventions for weight management in people with serious mental illness: a systematic review with meta-analysis, trial sequential analysis, and meta-regression analysis exploring the mediators and moderators of treatment effects. Psychother Psychosom. 2019, 88:350-62. 10.1159\/000502293","journal-title":"Psychother Psychosom"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2021.07.010","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"74","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol (Engl Ed). 2021, 74:790-9. 10.1016\/j.rec.2021.07.010","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.06.015","article-title":"Risk-of-bias assessment using Cochrane's revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: observations from a systematic review","volume":"161","author":"Crocker TF","year":"2023","unstructured":"Crocker TF, Lam N, Jord\u00e3o M, et al.. Risk-of-bias assessment using Cochrane's revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: observations from a systematic review. J Clin Epidemiol. 2023, 161:39-45. 10.1016\/j.jclinepi.2023.06.015","journal-title":"J Clin Epidemiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/524691-metabolic-protective-strategies-for-antipsychotic-associated-weight-gain-in-children-and-adolescents-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T14:18:07Z","timestamp":1786889887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/524691-metabolic-protective-strategies-for-antipsychotic-associated-weight-gain-in-children-and-adolescents-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,16]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.114599","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,16]]}}}